smooth muscle cells (SMCs), and macrophages as the sources of ROS, which oxidize LDL-C to oxidized LDL (ox-LDL). These oxidation reactions of lipid induce inflammation processes and lead to the production of inflammatory cytokines. Macrophages attract Ox-LDL and convert to foam cells. Apoptosis and growth factors released from foam cells, induce SMCs proliferation and migration into the intima. Finally, a fibrous plaque formed and rupture of fibrous plaque leads to thrombus development and occlusion of the vessel (5, 7) . Generally, the oxLDLs involved in several biological pathways including enhancing the expression of growth factors and related receptors, inducing ECM modification, activation phospholipase D, lactosylceramide generation and the sphingomyelin/ceramide (8) . Additionally, another mechanism of oxidative stress (by H2O2) that induces atherogenesis is through the activation of transcription factors such as nuclear factor-kappa B (NF-κB) and activator protein 1 (AP-1). These factors interfere with the expression of adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), E-selectin and other chemokines and cytokines. All these agents cause activation of NF-κB pathway that can be inactivated by antioxidants and antiinflammatory agents (9, 10) . Different enzymatic agents cause modification of LDL-C by oxidative stress that can refer to inducible nitric oxide synthase, NADPH oxidase, lipoxygenase, xanthine oxidase, myeloperoxidase, hemoxygenase-1, and ceruloplasmin (11) . To reduce the oxidative stress conditions, the administration of antioxidants can be effective, in which a wide range of research has been shown. The present review outlines the role of antioxidant in improvement and treatment atherosclerosis and focusing on new hopes in atherosclerosis.
Materials and Methods
PubMed/Medline, EBSCO, Embase, Web of Science, directory of open access journals (DOAJ), Scopus, and Google Scholar was searched (2000 to 2017) using the following keywords: atherosclerosis, antioxidant, cardiovascular disease, coronary artery disease, oxidative stress, insulin resistance, reactive oxygen species, diabetes mellitus, hypertension, hypercholesterolemia, macrophage, intracellular adhesion molecules and vascular cell adhesion molecule.
Results

Antioxidant therapy in atherosclerosis
Antioxidants are widely considered to be the most important of compounds in prevention or treatment of different diseases (e.g., cancer, Alzheimer's disease, arthritis, and diabetes) (12) . Numerous studies have confirmed the role of antioxidants in amelioration and the treatment of cardiovascular diseases such as atherosclerosis. For example, vitamin C, vitamin E, and polyphenols seem to be effective for cardiovascular diseases in clinical trials (13) . The enzymatic (e.g., glutathione peroxidase, superoxide dismutases, and catalase) and non-enzymatic systems to be used against ROS which can prevent cell membrane oxidation (14) .
The types of non-enzymatic antioxidants are included metabolic antioxidants and nutrient antioxidants. Metabolic antioxidants as endogenous antioxidants produced in the body that refers to glutathione, L-ariginine, bilirubin, coenzyme Q10, uric acid, melatonin, metalchelating proteins, lipoic acid, and transferrin. However, nutrient antioxidants exist in foods or supplements such as vitamin E, vitamin C, carotenoids, omega-3 and omega-6 fatty acids, selenium, and flavonoids (15) . For example, it has been suggested that uric acid increases cytokine production and inflammatory responses and additionally, the atherosclerotic lesion can be inhibited by lipoic acid supplement and unconjugated bilirubin in mice and human respectively. Vitamin E supplement possesses beneficial effect in the atherosclerotic lesion and delays its progression (8) . A recent study illustrated that tocopherols decrease SMC proliferation, platelet aggregation, and lipid peroxidation (16) . The anti-atherosclerotic effect of vitamin C is through inhibition of apoptosis and proapoptotic activity, induction of collagen synthesis, enhancing endothelial nitric oxide synthase (12) .
Recent review literature on this topic found that vitamin D can inhibit ROS-generating enzyme NADPH oxidase activity and inflammatory mediators in oxidative vascular injuries (17) . Flavonoids as herbal antioxidants have different therapeutic activities and neutralize free radicals. The antioxidant effects of these compounds in atherosclerosis are via preventing LDL oxidation in macrophage and reducing Ox-LDL attraction by macrophage receptors (18) .
Current trends of atherosclerosis
Recently, many new strategies have been used to prevent or treat atherosclerosis. Here we will refer to some of these strategies. Inflammatory processes play an important role in the pathogenesis of atherosclerosis that can be used as therapeutic targets. The study by Khan et al showed several inflammatory pathways appeared in animal models, which can be targeted by new anti-atherosclerotic therapeutics including inhibition of interleukin-1β (IL-1β), P selectin, serine protease and 5-lipoxygenase. The effect of IL-1β in atherosclerosis is through regulating leukocyte adhesion molecules, proliferation of VSMCs and production of other cytokines. Administration of IL-1β blockade can improve endothelial regrowth and cardiac remodeling and decrease cardiomyocyte apoptosis (19) .
RVX-208 as BET bromodomain inhibitor is well known in prevention and treatment of atherosclerosis or other metabolic disorders. This new drug can increase level of apolipoprotein A-I (apoA-I), high-density lipoprotein (HDL), pre-β-HDL, and α-1 HDL. The mechanism of RVX-208 in apoA-I level regulation is by binding to the BET protein and increasing apoA-I gene transcription that results in the production of this protein (20 
Conclusion
Atherosclerosis is a complex multifocal arterial disease associated with large and moderate arteries. It is caused by the interaction of multiple genetic and environmental factors. Oxidative stress plays a vital role in the pathogenesis of atherosclerosis and the use of antioxidants can prevent the progression of this disease. We conclude that antioxidant therapy can be useful in improving and treatment of atherosclerosis while further research on the issue is still required to extend our knowledge.
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